Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00412828
Status:
COMPLETED
Last Update Posted:
2015-02-19
First Post:
2006-12-18
Brief Title:
A Phase III Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma
Sponsor:
CuraGen Corporation
Organization:
Celldex Therapeutics
Organization Data
Organization:
Celldex Therapeutics
Class:
INDUSTRY
Study ID:
CR011-CLN-11
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CuraGen Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None